Weiping Peng

US Patent:

20100152200, Jun 17, 2010

Filed:

Nov 16, 2009

Appl. No.:

12/619117

Inventors:

David J. Miller - Chelsea MI, US
Daniel C. Peltier - Ann Arbor MI, US
Weiping Peng - Ann Arbor MI, US

Assignee:

THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI

International Classification:

A61K 31/496
C07D 495/04
A61K 31/454
C07D 401/14
A61P 31/12

US Classification:

51425309, 546198, 514321, 544364

Abstract:

The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides compounds as inhibitors of alphaviruses.

US Patent:

20050267050, Dec 1, 2005

Filed:

Mar 13, 2003

Appl. No.:

10/508424

Inventors:

Rabi Simantov - Rehovot, IL
Weiping Peng - Lincoln NE, US

Assignee:

YEDA RESEARCH AND DEVELOPMENT CO. LTD. - Rehovot

International Classification:

A61K031/704

US Classification:

514026000

Abstract:

This invention relates to methods and compositions for treating or preventing the symptoms associated with toxicity induced by ingestion of MDMA. In one aspect, the present invention is related to methods for treating or preventing the symptoms associated with MDMA, or MDMA-related psychoactive drugs by administering to a subject in need thereof a composition that includes a therapeutically effective amount of an agent which inhibits γ-amino butyric acid (GABA) transporter activity or reduces GABA transporter level in the brain.